Skip to main content Skip to section navigation Skip to footer
Careers Resources Contact
Codexis, Inc.
  • Home
  • About Us
    • Overview
    • Social Responsibility
    • News
    • Events
    • History
    • Management Team
    • Board of Directors
  • Focus Areas
    • Overview
    • Biotherapeutics
    • Life Science Tools
    • Pharmaceutical Manufacturing
    • Food, Beverage & Nutrition
    • Industrial Applications
  • Technology
  • Products
    • Overview
    • Life Science Enzymes
    • Biocatalysts
  • Partnerships
    • Overview
    • Discovery and Development
    • Scale-up and Supply
    • Our Partners
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Resources
  • Contact
  • Search

Press Releases at Codexis

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jan 10, 2020 7:00am EST

Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement

Dec 23, 2019 7:00am EST

Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing

Dec 05, 2019 4:05pm EST

Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir

Nov 05, 2019 4:05pm EST

Codexis Reports Third Quarter 2019 Financial Results

Nov 05, 2019 7:00am EST

Codexis to Participate in Four Investment Conferences in November

Oct 29, 2019 7:00am EDT

Codexis to Hold Third Quarter 2019 Conference Call on November 5

Oct 15, 2019 4:05pm EDT

Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field

Sep 26, 2019 8:00am EDT

Codexis Spreading the Promise of Engineered Proteins at SynBioBeta Summit

Sep 26, 2019 7:00am EDT

Codexis to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

Aug 06, 2019 4:06pm EDT

Codexis Reports Second Quarter 2019 Financial Results

  • arrow_back
  • 1…
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …16
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Twitter Linkedin
  • Sitemap
  • Terms of Sale
  • Trademarks
  • Patents
  • Terms of Use
  • Privacy
  • Disclaimer
©2022 Codexis, Inc. All Rights Reserved.